Autoantibody landscapes in neurological Long COVID and post-COVID cognitive impairment show heterogeneity without a shared disease signature
Brian K. Agan, Samuel J. Pleasure, Kelsey C. Zorn, Stephanie A Richard et al.
Journal
medRxiv
Topics
Long-Term Effects of COVID-19
article
Autoantibody landscapes in neurological Long COVID and post-COVID cognitive impairment show heterogeneity without a shared disease signature
Brian K. Agan, Samuel J. Pleasure, Kelsey C. Zorn, Stephanie A Richard, Aditi Saxena, Jennifer Chiarella, Lindsay S. McAlpine, Mary E. Wilson, Iris Tilton, Serena Spudich, Debanjana Chakravarty, David R. Tribble, Ravi Dandekar, Vishal D Lashkari, Grace Wang, Peixi Chen, Allison Nelson, Bryan Castillo-Rojas, Thomas T. Ngo, Timothy H. Burgess, Shelli Farhadian, Leah H. Rubin, Simon D. Pollett
article en
Abstract
No abstract available for this paper.
Publication Tag
medRxiv
Institutions
Henry M. Jackson Foundation (US), Johns Hopkins University (US), Uniformed Services University of the Health Sciences (US), University of California, San Francisco (US), Johns Hopkins Medicine (US), Yale University (US), Behavioral Pharma (United States) (US), Yale New Haven Health System (US), Johns Hopkins Hospital (US)